ExonHit Therapeutics SA (Alzheimer diagnostics)
Seite 1 von 1 Neuester Beitrag: 19.02.12 14:38 | ||||
Eröffnet am: | 19.02.12 14:38 | von: Hornissen | Anzahl Beiträge: | 1 |
Neuester Beitrag: | 19.02.12 14:38 | von: Hornissen | Leser gesamt: | 692 |
Forum: | Börse | Leser heute: | 1 | |
Bewertet mit: | ||||
Key Numbers
Market cap 45.6M EUR
Sales 8.5M EUR
Quarterly revenue growth 22% ( this is very important as from here it accellerates, actually revenues were increasing from the start but with latest collaboration with Allergan Inc. and Bristol Myers Squibb revenues will increase even faster)
EPS, Income, EBITDA all negative as company till lately was in development stage, but now there is a real product in Alzheimer's diagnostics, potential to so big that nobody cares about balance sheet here)
Cash 26M EUR
LT Debt 7M EUR (very nicely managed when it comes to debt, even from quantitative view there is risk for the stock)
Assets 45M EUR
Liabilities 17.5M EUR (here also no problem as you assets are much higher than liabilities, besides 50% of market cap is cash, it's rare as diamonds you will find today walking on the street, ExonHit is not only in medical diagnostics, they have some therapeutics too but in early phases)
Employees 66 from them 46 are scientists, 5 executives running company are Phd. , M.D& MBA graduates
Shares Outstanding 33,300,000
Ffree Float 30,600,000 (I just imagine somebody will start increasing position here, it will be very nice to see it coming)
Major Investors:
Oxford Bioscience Partners Group 7.8%
Groupe PRO BTP 3%
Other institutions 5.3%
Finally